Successful treatment with meloxicam, a cyclooxygenase-2 inhibitor, of patients with extra-abdominal desmoid tumors: A pilot study

Journal of Clinical Oncology

Volumn 28, Issue 6, 2010, Pages

  Nishida, Yoshihiro ^a   Tsukushi, Satoshi ^a   Shido, Yoji ^a   Wasa, Junji ^a   Ishiguro, Naoki ^a   Yamada, Yoshihisa ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nagoya Memorial Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MELOXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ABDOMINAL FIBROMATOSIS; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; DESMOID TUMOR; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENZYME INHIBITION; EXTRA ABDOMINAL DESMOID TUMOR; FOLLOW UP; GASTRITIS; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PILOT STUDY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT RESPONSE; TUMOR CELL CULTURE; TUMOR GROWTH; TUMOR LOCALIZATION; ADULT; AGED; CHEMISTRY; ENZYME IMMUNOASSAY; FEMALE; FIBROMATOSIS; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; THIAZINES; THIAZOLES; YOUNG ADULT;

EID: 77949911878     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.5950     Document Type: Letter

References (6)

1. Oshima M, Dinchuk JE, Kargman SL, et al: Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803-809, 1996 (Pubitemid 26404280)
2. Poon R, Smits R, Li C, et al: Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 20:451-460, 2001
3. Shido Y, Nishida Y, Nakashima H, et al: Surgical treatment for local control of extremity and trunk desmoid tumors. Arch Orthop Trauma Surg 129:929-933, 2009
4. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216, 2000
5. Naruse T, Nishida Y, Hosono K, et al: Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes. Carcinogenesis 27:584-592, 2006 (Pubitemid 43378898)
6. Urakawa H, Nishida Y, Naruse T, et al: Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: A pilot study. Clin Orthop Relat Res 467:2932-2938, 2009